603896
vs
S
Shanghai Composite
603896
Over the past 12 months, Zhejiang Shouxiangu Pharmaceutical Co Ltd has underperformed Shanghai Composite, delivering a return of +3% compared to the Shanghai Composite's +28% growth.
Stocks Performance
603896 vs Shanghai Composite
Performance Gap
603896 vs Shanghai Composite
Performance By Year
603896 vs Shanghai Composite
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Zhejiang Shouxiangu Pharmaceutical Co Ltd
Glance View
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the breeding, cultivation, processing, and sale of Chinese herbal pieces and health food. The company is headquartered in Jinhua, Zhejiang and currently employs 1,026 full-time employees. The company went IPO on 2017-05-10. The firm's main products include ganoderma lucidum spore powder, Tiepi Fengdou granule, ganoderma extract products and fresh dendrobium officinales, among others. The firm mainly operates its businesses in domestic markets through wholesaling and direct sales.